187-1, N-WASP inhibitor peptide
Not For Human Use, Lab Use Only.
Cat.#: 319800
Special Price 779.00 USD
-
Product Name
187-1, N-WASP inhibitor peptide
-
Documents
Batch to batch variation of the purity
-
Sequence Shortening
Cyclo[QK-{d-Phe}-{d-Pro}-{d-Phe}-F-{d-Pro}-QK-{d-Phe}-{d-Pro}-{d-Phe}-F-{d-Pro}]
-
Sequence
Cyclo[Gln-Lys-{d-Phe}-{d-Pro}-{d-Phe}-Phe-{d-Pro}-Gln-Lys-{d-Phe}-{d-Pro}-{d-Phe}-Phe-{d-Pro}]
-
Length (aa)
14
-
Peptide Purity (HPLC)
95%
-
Molecular Formula
C96H122N18O16
-
Molecular Weight
1784.11
-
CAS No.
380488-27-7
-
PubChem CID
44405676
-
Source
Synthetic
-
Form
Powder
-
Description
The cyclic peptide 187-1 is a 14-amino acid inhibitor identified through a high-throughput screen targeting actin polymerization pathways. This compound specifically binds to N-WASP (Neural Wiskott-Aldrich Syndrome Protein), a key regulator of actin cytoskeleton dynamics. By allosterically stabilizing the autoinhibited conformation of N-WASP, 187-1 prevents its interaction with the Arp2/3 complex, thereby blocking PIP2-induced actin assembly. Biochemical assays and photo-crosslinking studies confirm that 187-1 directly interacts with N-WASP, demonstrating its role as a selective modulator of protein-protein interactions.
Structural analysis reveals that 187-1, a cyclodimeric peptide, exhibits high binding affinity for N-WASP, with an IC50 of ~2 μM in inhibiting actin polymerization. Unlike linear peptides, its cyclic structure confers proteolytic stability and enhances target specificity. The inhibitory mechanism involves competition with activators such as cdc42, reinforcing the autoinhibited state of N-WASP. This peptide provides a valuable tool for probing N-WASP-dependent signaling pathways and elucidating the structural basis of allosteric inhibition in cytoskeletal regulation.
-
Storage Guidelines
Normally, this peptide will be delivered in lyophilized form and should be stored in a freezer at or below -20 °C. For more details, please refer to the manual: Handling and Storage of Synthetic Peptides
-
References
- Peterson JR, Lokey RS, Mitchison TJ, Kirschner MW. A chemical inhibitor of N-WASP reveals a new mechanism for targeting protein interactions. Proc Natl Acad Sci U S A. 2001 Sep 11;98(19):10624-9. doi: 10.1073/pnas.201393198. PMID: 11553809; PMCID: PMC58516.
-
About TFA salt
Trifluoroacetic acid (TFA) is a common counterion from the purification process using High-Performance Liquid Chromatography (HPLC). The presence of TFA can affect the peptide's net weight, appearance, and solubility.
Impact on Net Weight: The TFA salt contributes to the total mass of the product. In most cases, the peptide content constitutes >80% of the total weight, with TFA accounting for the remainder.
Solubility: TFA salts generally enhance the solubility of peptides in aqueous solutions.
In Biological Assays: For most standard in vitro assays, the residual TFA levels do not cause interference. However, for highly sensitive cellular or biochemical studies, please be aware of its presence.
-
Molar Concentration Calculator
-
Dilution Calculator
-
Percent Concentration Calculator
Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)
Related Products / Services
• Peptide Services: NovoPro's peptide synthesis services include standard chemical peptide synthesis, peptide modification, peptide libraries, and recombinant peptide expression.
• Standard Peptide Synthesis: NovoPro offers quality peptides at the most competitive prices in the industry, starting at $3.20 per amino acid. NovoPro provides PepBox – Automatic Quote Tool for online price calculation.
• Peptide Modifications: NovoPro offers a wide range of peptide modification services including isotope labeling (2H, 15N, and 13C), multiple disulfide bonds, multiple phosphorylations, KLH, BSA, ovalbumin, amidation, acetylation, biotin, FITC, etc.
Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"